Development of a specific anti-leukaemic serum for the treatment of leukaemia in clinics.
D000372:Agglutination Tests; D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D001789:Blood Group Antigens; D001799:Blood Sedimentation; D002449:Cell Aggregation; D002498:Centrifugation; D005461:Fluorine; D006736:Horses; D006801:Humans; D007106:Immune Sera / Q000302:isolation & purification*; D007116:Immunization, Passive; D005779:Immunodiffusion; D007945:Leukemia, Lymphoid / Q000175:diagnosis*; D007951:Leukemia, Myeloid / Q000175:diagnosis*; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D009578:Nitrobenzenes / Q000494:pharmacology; D011233:Precipitin Tests
D001789:Blood Group Antigens; D007106:Immune Sera; D009578:Nitrobenzenes; D005461:Fluorine